Lexaria Bioscience (LEXX) Shareholder's Equity Growth (3y) (2013 - 2026)
Lexaria Bioscience (LEXX) Shareholder's Equity Growth (3y) (2013 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
| 10 |
Lexaria Bioscience |
7.17 Mn |
1.65 Mn |
20,000.00 |
| Date | Value |
|---|
| Feb 28, 2026 |
12.54% |
| Nov 30, 2025 |
-8.64% |
| Aug 31, 2025 |
-26.83% |
| May 31, 2025 |
-16.62% |
| Feb 28, 2025 |
-15.54% |
| Nov 30, 2024 |
-6.43% |
| Aug 31, 2024 |
-16.30% |
| May 31, 2024 |
-1.71% |
| Feb 29, 2024 |
-19.31% |
| Nov 30, 2023 |
22.81% |
| Aug 31, 2023 |
2.59% |
| May 31, 2023 |
8.08% |
| Feb 28, 2023 |
34.05% |
| Nov 30, 2022 |
31.39% |
| Aug 31, 2022 |
45.25% |
| May 31, 2022 |
38.91% |
| Feb 28, 2022 |
43.80% |
| Nov 30, 2021 |
49.76% |
| Aug 31, 2021 |
76.20% |
| May 31, 2021 |
57.30% |
